Bausch Health Companies Inc.
NYSEBausch Health Companies enters the week after one of its worst monthly stretches in recent memory, with the stock off nearly 13% in a month and the options market deeply skewed toward downside protection — yet the borrow market shows no urgency at all. The clearest signal this week is the put/call ratio. Options traders are running heavily defensive, with the PCR at 1.87 — well…
Snapshot as of 20 Sept 2026
Bausch Health Companies enters the week after one of its worst monthly stretches in recent memory, with the stock off nearly 13% in a month and the options market deeply skewed toward downside protection — yet the…
Bausch Health Companies enters its Q2 print today with the stock up 3.5% on the session to $4.68 — still trading at a steep discount to the Street's mean target of $7.30, a gap that has persisted all month and frames…
Bausch Health Companies reports tomorrow with a quietly interesting setup: short interest has climbed 22% over the past month, the ORTEX short score has drifted higher all week, and the stock trades at $4.52 — roughly…
Bausch Health Companies Inc. heads into its May 7 Q1 results with the most bullish options read in nearly a year — a sharp contrast to the heavy put positioning that defined most of 2026. The standout this week is the…
BHC heads into its April 29 Q1 results with options markets flashing an unusually bullish lean — a notable contrast to the cautious positioning more typical ahead of a heavily indebted pharma print. The options signal…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BHC — free to start on ORTEX.
Sign up for free →Open BHC on ORTEX